The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions
There is increasing evidence that frontotemporal dementia and amyotrophic lateral sclerosis are part of a disease continuum. Recently, a hexanucleotide repeat expansion in C9orf72 was identified as a major cause of both sporadic and familial frontotemporal dementia and amyotrophic lateral sclerosis....
Saved in:
Published in | Brain (London, England : 1878) Vol. 135; no. 3; pp. 723 - 735 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Oxford University Press
01.03.2012
|
Subjects | |
Online Access | Get full text |
ISSN | 0006-8950 1460-2156 1460-2156 |
DOI | 10.1093/brain/awr353 |
Cover
Abstract | There is increasing evidence that frontotemporal dementia and amyotrophic lateral sclerosis are part of a disease continuum. Recently, a hexanucleotide repeat expansion in C9orf72 was identified as a major cause of both sporadic and familial frontotemporal dementia and amyotrophic lateral sclerosis. The aim of this study was to investigate clinical and neuropathological characteristics of hexanucleotide repeat expansions in C9orf72 in a large cohort of Dutch patients with frontotemporal dementia. Repeat expansions were successfully determined in a cohort of 353 patients with sporadic or familial frontotemporal dementia with or without amyotrophic lateral sclerosis, and 522 neurologically normal controls. Immunohistochemistry was performed in a series of 10 brains from patients carrying expanded repeats using a panel of antibodies. In addition, the presence of RNA containing GGGGCC repeats in paraffin-embedded sections of post-mortem brain tissue was investigated using fluorescence in situ hybridization with a locked nucleic acid probe targeting the GGGGCC repeat. Hexanucleotide repeat expansions in C9orf72 were found in 37 patients with familial (28.7%) and five with sporadic frontotemporal dementia (2.2%). The mean age at onset was 56.9 ± 8.3 years (range 39-76), and disease duration 7.6 ± 4.6 years (range 1-22). The clinical phenotype of these patients varied between the behavioural variant of frontotemporal dementia (n = 34) and primary progressive aphasia (n = 8), with concomitant amyotrophic lateral sclerosis in seven patients. Predominant temporal atrophy on neuroimaging was present in 13 of 32 patients. Pathological examination of the 10 brains from patients carrying expanded repeats revealed frontotemporal lobar degeneration with neuronal transactive response DNA binding protein-positive inclusions of variable type, size and morphology in all brains. Fluorescence in situ hybridization analysis of brain material from patients with the repeat expansion, a microtubule-associated protein tau or a progranulin mutation, and controls did not show RNA-positive inclusions specific for brains with the GGGGCC repeat expansion. The hexanucleotide repeat expansion in C9orf72 is an important cause of frontotemporal dementia with and without amyotrophic lateral sclerosis, and is sometimes associated with primary progressive aphasia. Neuropathological hallmarks include neuronal and glial inclusions, and dystrophic neurites containing transactive response DNA binding protein. Future studies are needed to explain the wide variation in clinical presentation. |
---|---|
AbstractList | There is increasing evidence that frontotemporal dementia and amyotrophic lateral sclerosis are part of a disease continuum. Recently, a hexanucleotide repeat expansion in C9orf72 was identified as a major cause of both sporadic and familial frontotemporal dementia and amyotrophic lateral sclerosis. The aim of this study was to investigate clinical and neuropathological characteristics of hexanucleotide repeat expansions in C9orf72 in a large cohort of Dutch patients with frontotemporal dementia. Repeat expansions were successfully determined in a cohort of 353 patients with sporadic or familial frontotemporal dementia with or without amyotrophic lateral sclerosis, and 522 neurologically normal controls. Immunohistochemistry was performed in a series of 10 brains from patients carrying expanded repeats using a panel of antibodies. In addition, the presence of RNA containing GGGGCC repeats in paraffin-embedded sections of post-mortem brain tissue was investigated using fluorescence in situ hybridization with a locked nucleic acid probe targeting the GGGGCC repeat. Hexanucleotide repeat expansions in C9orf72 were found in 37 patients with familial (28.7%) and five with sporadic frontotemporal dementia (2.2%). The mean age at onset was 56.9 plus or minus 8.3 years (range 39-76), and disease duration 7.6 plus or minus 4.6 years (range 1-22). The clinical phenotype of these patients varied between the behavioural variant of frontotemporal dementia (n = 34) and primary progressive aphasia (n = 8), with concomitant amyotrophic lateral sclerosis in seven patients. Predominant temporal atrophy on neuroimaging was present in 13 of 32 patients. Pathological examination of the 10 brains from patients carrying expanded repeats revealed frontotemporal lobar degeneration with neuronal transactive response DNA binding protein-positive inclusions of variable type, size and morphology in all brains. Fluorescence in situ hybridization analysis of brain material from patients with the repeat expansion, a microtubule-associated protein tau or a progranulin mutation, and controls did not show RNA-positive inclusions specific for brains with the GGGGCC repeat expansion. The hexanucleotide repeat expansion in C9orf72 is an important cause of frontotemporal dementia with and without amyotrophic lateral sclerosis, and is sometimes associated with primary progressive aphasia. Neuropathological hallmarks include neuronal and glial inclusions, and dystrophic neurites containing transactive response DNA binding protein. Future studies are needed to explain the wide variation in clinical presentation. There is increasing evidence that frontotemporal dementia and amyotrophic lateral sclerosis are part of a disease continuum. Recently, a hexanucleotide repeat expansion in C9orf72 was identified as a major cause of both sporadic and familial frontotemporal dementia and amyotrophic lateral sclerosis. The aim of this study was to investigate clinical and neuropathological characteristics of hexanucleotide repeat expansions in C9orf72 in a large cohort of Dutch patients with frontotemporal dementia. Repeat expansions were successfully determined in a cohort of 353 patients with sporadic or familial frontotemporal dementia with or without amyotrophic lateral sclerosis, and 522 neurologically normal controls. Immunohistochemistry was performed in a series of 10 brains from patients carrying expanded repeats using a panel of antibodies. In addition, the presence of RNA containing GGGGCC repeats in paraffin-embedded sections of post-mortem brain tissue was investigated using fluorescence in situ hybridization with a locked nucleic acid probe targeting the GGGGCC repeat. Hexanucleotide repeat expansions in C9orf72 were found in 37 patients with familial (28.7%) and five with sporadic frontotemporal dementia (2.2%). The mean age at onset was 56.9 ± 8.3 years (range 39-76), and disease duration 7.6 ± 4.6 years (range 1-22). The clinical phenotype of these patients varied between the behavioural variant of frontotemporal dementia (n = 34) and primary progressive aphasia (n = 8), with concomitant amyotrophic lateral sclerosis in seven patients. Predominant temporal atrophy on neuroimaging was present in 13 of 32 patients. Pathological examination of the 10 brains from patients carrying expanded repeats revealed frontotemporal lobar degeneration with neuronal transactive response DNA binding protein-positive inclusions of variable type, size and morphology in all brains. Fluorescence in situ hybridization analysis of brain material from patients with the repeat expansion, a microtubule-associated protein tau or a progranulin mutation, and controls did not show RNA-positive inclusions specific for brains with the GGGGCC repeat expansion. The hexanucleotide repeat expansion in C9orf72 is an important cause of frontotemporal dementia with and without amyotrophic lateral sclerosis, and is sometimes associated with primary progressive aphasia. Neuropathological hallmarks include neuronal and glial inclusions, and dystrophic neurites containing transactive response DNA binding protein. Future studies are needed to explain the wide variation in clinical presentation. There is increasing evidence that frontotemporal dementia and amyotrophic lateral sclerosis are part of a disease continuum. Recently, a hexanucleotide repeat expansion in C9orf72 was identified as a major cause of both sporadic and familial frontotemporal dementia and amyotrophic lateral sclerosis. The aim of this study was to investigate clinical and neuropathological characteristics of hexanucleotide repeat expansions in C9orf72 in a large cohort of Dutch patients with frontotemporal dementia. Repeat expansions were successfully determined in a cohort of 353 patients with sporadic or familial frontotemporal dementia with or without amyotrophic lateral sclerosis, and 522 neurologically normal controls. Immunohistochemistry was performed in a series of 10 brains from patients carrying expanded repeats using a panel of antibodies. In addition, the presence of RNA containing GGGGCC repeats in paraffin-embedded sections of post-mortem brain tissue was investigated using fluorescence in situ hybridization with a locked nucleic acid probe targeting the GGGGCC repeat. Hexanucleotide repeat expansions in C9orf72 were found in 37 patients with familial (28.7%) and five with sporadic frontotemporal dementia (2.2%). The mean age at onset was 56.9 ± 8.3 years (range 39-76), and disease duration 7.6 ± 4.6 years (range 1-22). The clinical phenotype of these patients varied between the behavioural variant of frontotemporal dementia (n = 34) and primary progressive aphasia (n = 8), with concomitant amyotrophic lateral sclerosis in seven patients. Predominant temporal atrophy on neuroimaging was present in 13 of 32 patients. Pathological examination of the 10 brains from patients carrying expanded repeats revealed frontotemporal lobar degeneration with neuronal transactive response DNA binding protein-positive inclusions of variable type, size and morphology in all brains. Fluorescence in situ hybridization analysis of brain material from patients with the repeat expansion, a microtubule-associated protein tau or a progranulin mutation, and controls did not show RNA-positive inclusions specific for brains with the GGGGCC repeat expansion. The hexanucleotide repeat expansion in C9orf72 is an important cause of frontotemporal dementia with and without amyotrophic lateral sclerosis, and is sometimes associated with primary progressive aphasia. Neuropathological hallmarks include neuronal and glial inclusions, and dystrophic neurites containing transactive response DNA binding protein. Future studies are needed to explain the wide variation in clinical presentation.There is increasing evidence that frontotemporal dementia and amyotrophic lateral sclerosis are part of a disease continuum. Recently, a hexanucleotide repeat expansion in C9orf72 was identified as a major cause of both sporadic and familial frontotemporal dementia and amyotrophic lateral sclerosis. The aim of this study was to investigate clinical and neuropathological characteristics of hexanucleotide repeat expansions in C9orf72 in a large cohort of Dutch patients with frontotemporal dementia. Repeat expansions were successfully determined in a cohort of 353 patients with sporadic or familial frontotemporal dementia with or without amyotrophic lateral sclerosis, and 522 neurologically normal controls. Immunohistochemistry was performed in a series of 10 brains from patients carrying expanded repeats using a panel of antibodies. In addition, the presence of RNA containing GGGGCC repeats in paraffin-embedded sections of post-mortem brain tissue was investigated using fluorescence in situ hybridization with a locked nucleic acid probe targeting the GGGGCC repeat. Hexanucleotide repeat expansions in C9orf72 were found in 37 patients with familial (28.7%) and five with sporadic frontotemporal dementia (2.2%). The mean age at onset was 56.9 ± 8.3 years (range 39-76), and disease duration 7.6 ± 4.6 years (range 1-22). The clinical phenotype of these patients varied between the behavioural variant of frontotemporal dementia (n = 34) and primary progressive aphasia (n = 8), with concomitant amyotrophic lateral sclerosis in seven patients. Predominant temporal atrophy on neuroimaging was present in 13 of 32 patients. Pathological examination of the 10 brains from patients carrying expanded repeats revealed frontotemporal lobar degeneration with neuronal transactive response DNA binding protein-positive inclusions of variable type, size and morphology in all brains. Fluorescence in situ hybridization analysis of brain material from patients with the repeat expansion, a microtubule-associated protein tau or a progranulin mutation, and controls did not show RNA-positive inclusions specific for brains with the GGGGCC repeat expansion. The hexanucleotide repeat expansion in C9orf72 is an important cause of frontotemporal dementia with and without amyotrophic lateral sclerosis, and is sometimes associated with primary progressive aphasia. Neuropathological hallmarks include neuronal and glial inclusions, and dystrophic neurites containing transactive response DNA binding protein. Future studies are needed to explain the wide variation in clinical presentation. |
Author | Heutink, Peter de Graaf, J. Roos A. de Koning, Inge van Schoor, Natasja M. Dopper, Elise G. P. Nicolaou, Nayia Deeg, Dorly J. H. Seelaar, Harro Smits, Marion Simón-Sánchez, Javier Raaphorst, Joost Pijnenburg, Yolande A. L. van Swieten, John C. van den Berg, Leonard H. De Die-Smulders, Christine E. M. Cohn-Hokke, Petra E. Majoor-Krakauer, Danielle Schelhaas, Helenius J. Willemsen, Rob Rozemuller, Annemieke J. M. Hukema, Renate K. |
Author_xml | – sequence: 1 givenname: Javier surname: Simón-Sánchez fullname: Simón-Sánchez, Javier – sequence: 2 givenname: Elise G. P. surname: Dopper fullname: Dopper, Elise G. P. – sequence: 3 givenname: Petra E. surname: Cohn-Hokke fullname: Cohn-Hokke, Petra E. – sequence: 4 givenname: Renate K. surname: Hukema fullname: Hukema, Renate K. – sequence: 5 givenname: Nayia surname: Nicolaou fullname: Nicolaou, Nayia – sequence: 6 givenname: Harro surname: Seelaar fullname: Seelaar, Harro – sequence: 7 givenname: J. Roos A. surname: de Graaf fullname: de Graaf, J. Roos A. – sequence: 8 givenname: Inge surname: de Koning fullname: de Koning, Inge – sequence: 9 givenname: Natasja M. surname: van Schoor fullname: van Schoor, Natasja M. – sequence: 10 givenname: Dorly J. H. surname: Deeg fullname: Deeg, Dorly J. H. – sequence: 11 givenname: Marion surname: Smits fullname: Smits, Marion – sequence: 12 givenname: Joost surname: Raaphorst fullname: Raaphorst, Joost – sequence: 13 givenname: Leonard H. surname: van den Berg fullname: van den Berg, Leonard H. – sequence: 14 givenname: Helenius J. surname: Schelhaas fullname: Schelhaas, Helenius J. – sequence: 15 givenname: Christine E. M. surname: De Die-Smulders fullname: De Die-Smulders, Christine E. M. – sequence: 16 givenname: Danielle surname: Majoor-Krakauer fullname: Majoor-Krakauer, Danielle – sequence: 17 givenname: Annemieke J. M. surname: Rozemuller fullname: Rozemuller, Annemieke J. M. – sequence: 18 givenname: Rob surname: Willemsen fullname: Willemsen, Rob – sequence: 19 givenname: Yolande A. L. surname: Pijnenburg fullname: Pijnenburg, Yolande A. L. – sequence: 20 givenname: Peter surname: Heutink fullname: Heutink, Peter – sequence: 21 givenname: John C. surname: van Swieten fullname: van Swieten, John C. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25589896$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22300876$$D View this record in MEDLINE/PubMed |
BookMark | eNp90c9rFDEUB_AgFbtdvXmWuYgeHJvfmzmWxapQKGg9h7eZFzcym4xJFtv_3rS7RRDx9CB83iN8v2fkJKaIhLxk9D2jgzjfZAjxHH5locQTsmBS054zpU_IglKqezMoekrOSvlBKZOC62fklHNBqVnpBfl6s8XOTSEGB1MHcexmqNs0pe8PD_MWY6p3M3bJd-vh-svlindbvIW4dxOmGkbsMs4ItcPbGWIJKZbn5KmHqeCL41ySb5cfbtaf-qvrj5_XF1e9k2pVe66Rcae8RIaGS800gpTGc4cjDu3vHhhw4JpKuvGCD-jNuDFCwUoaYCiW5M3h7pzTzz2WanehOJwmiJj2xQ5cDMoowZt8-1_ZcpGUC9Pmkrw60v1mh6Odc9hBvrOPkTXw-gigtIh8huhC-eOUMoMZ7h0_OJdTKRm9daFCbQHV1thkGbX3_dmH_uyhv7b07q-lx7v_5L8BEh2dnQ |
CitedBy_id | crossref_primary_10_1371_journal_pone_0056899 crossref_primary_10_1007_s00401_015_1476_2 crossref_primary_10_3389_fnmol_2014_00063 crossref_primary_10_1016_j_cortex_2021_09_005 crossref_primary_10_1007_s00401_012_1050_0 crossref_primary_10_1038_s41398_019_0381_1 crossref_primary_10_1016_j_nicl_2020_102300 crossref_primary_10_1016_j_neurobiolaging_2019_07_007 crossref_primary_10_1007_s00401_012_1029_x crossref_primary_10_1534_genetics_115_179457 crossref_primary_10_1016_j_neurobiolaging_2019_10_017 crossref_primary_10_1212_01_wnl_0000436063_12890_b2 crossref_primary_10_1093_brain_awt030 crossref_primary_10_1111_ahg_12033 crossref_primary_10_1176_appi_neuropsych_16090168 crossref_primary_10_1007_s00415_021_10575_w crossref_primary_10_3390_cells10020249 crossref_primary_10_1016_j_mcn_2012_12_006 crossref_primary_10_1016_j_neubiorev_2017_01_004 crossref_primary_10_1093_brain_awu248 crossref_primary_10_1016_S1474_4422_14_70233_9 crossref_primary_10_1002_ana_26677 crossref_primary_10_1016_j_neurobiolaging_2012_10_003 crossref_primary_10_1186_alzrt133 crossref_primary_10_1007_s00401_012_0970_z crossref_primary_10_1007_s00401_013_1088_7 crossref_primary_10_1016_j_biopsych_2013_01_031 crossref_primary_10_1016_j_neurol_2013_07_010 crossref_primary_10_1186_s40478_015_0238_7 crossref_primary_10_1186_alzrt132 crossref_primary_10_7554_eLife_62718 crossref_primary_10_1007_s00401_014_1253_7 crossref_primary_10_1016_j_neurobiolaging_2017_12_015 crossref_primary_10_3390_jpm13091396 crossref_primary_10_1016_j_neurol_2013_07_014 crossref_primary_10_1186_alzrt136 crossref_primary_10_1002_mds_25838 crossref_primary_10_1007_s00401_017_1716_8 crossref_primary_10_15252_embr_201540607 crossref_primary_10_1038_nrneurol_2012_117 crossref_primary_10_1186_alzrt130 crossref_primary_10_1016_j_neurobiolaging_2019_02_006 crossref_primary_10_3233_JAD_160236 crossref_primary_10_1136_jnnp_2022_330152 crossref_primary_10_1002_alz_13551 crossref_primary_10_1101_cshperspect_a024133 crossref_primary_10_1038_s41467_022_33332_7 crossref_primary_10_1038_s41598_017_08857_3 crossref_primary_10_1080_13554794_2015_1080283 crossref_primary_10_1093_brain_awab410 crossref_primary_10_1093_hmg_ddt349 crossref_primary_10_1111_bpa_12354 crossref_primary_10_1097_WCO_0b013e32835a3efb crossref_primary_10_3389_fnagi_2015_00171 crossref_primary_10_1002_mdc3_12677 crossref_primary_10_1016_j_cortex_2021_12_014 crossref_primary_10_1038_s41582_018_0009_8 crossref_primary_10_1136_bcr_2013_203458 crossref_primary_10_1590_0004_282X20140229 crossref_primary_10_3109_21678421_2016_1140786 crossref_primary_10_1007_s13311_015_0342_1 crossref_primary_10_1002_humu_22164 crossref_primary_10_1016_j_neurobiolaging_2013_07_016 crossref_primary_10_1101_cshperspect_a024224 crossref_primary_10_1016_j_neurobiolaging_2013_03_006 crossref_primary_10_3389_fnagi_2022_841711 crossref_primary_10_1016_j_neurobiolaging_2012_05_002 crossref_primary_10_1016_j_neubiorev_2016_03_033 crossref_primary_10_1016_j_neurol_2024_03_008 crossref_primary_10_1007_s11910_012_0268_5 crossref_primary_10_1111_nan_12845 crossref_primary_10_1590_S1980_57642013DN70100002 crossref_primary_10_1111_nan_12284 crossref_primary_10_1016_j_pneurobio_2022_102229 crossref_primary_10_1016_S1474_4422_13_70026_7 crossref_primary_10_1111_jnc_13654 crossref_primary_10_1007_s12264_020_00567_7 crossref_primary_10_1093_brain_aws357 crossref_primary_10_1093_hmg_ddu576 crossref_primary_10_3109_21678421_2014_959450 crossref_primary_10_1016_j_stemcr_2020_01_010 crossref_primary_10_3109_21678421_2013_765485 crossref_primary_10_1080_02687038_2014_911242 crossref_primary_10_1007_s00401_013_1125_6 crossref_primary_10_1212_WNL_0000000000010914 crossref_primary_10_1007_s00401_013_1149_y crossref_primary_10_1016_S1474_4422_12_70043_1 crossref_primary_10_1111_ene_12211 crossref_primary_10_1016_j_tins_2013_04_010 crossref_primary_10_1016_j_gde_2017_02_008 crossref_primary_10_3109_17482968_2012_725415 crossref_primary_10_3109_21678421_2015_1111904 crossref_primary_10_3389_fgene_2018_00712 crossref_primary_10_1212_WNL_0b013e318268471a crossref_primary_10_1093_brain_aws230 crossref_primary_10_3389_fneur_2022_861585 crossref_primary_10_1002_ajmg_b_32080 crossref_primary_10_1016_j_arr_2020_101172 crossref_primary_10_1016_j_parkreldis_2014_07_010 crossref_primary_10_1002_ana_25271 crossref_primary_10_3233_JAD_161142 crossref_primary_10_1016_j_neurol_2012_10_003 crossref_primary_10_3233_JAD_200795 crossref_primary_10_1016_j_jns_2013_09_013 crossref_primary_10_1016_j_nicl_2016_12_006 crossref_primary_10_1097_NRL_0000000000000147 crossref_primary_10_3233_JAD_150922 crossref_primary_10_1038_nrneurol_2014_159 crossref_primary_10_1016_j_neurobiolaging_2015_11_016 crossref_primary_10_1111_j_1440_1789_2012_01332_x crossref_primary_10_3389_fneur_2020_550140 crossref_primary_10_1007_s00401_013_1181_y crossref_primary_10_1016_j_neurol_2015_04_004 crossref_primary_10_1080_13554794_2014_951058 crossref_primary_10_1093_brain_aws144 crossref_primary_10_1186_s13024_022_00525_z crossref_primary_10_1002_mds_25245 crossref_primary_10_1111_nan_12100 crossref_primary_10_2298_GENSR2301001M crossref_primary_10_1007_s00401_014_1251_9 crossref_primary_10_1016_j_nicl_2013_06_005 crossref_primary_10_1101_cshperspect_a026757 crossref_primary_10_1080_15548627_2015_1121360 crossref_primary_10_1021_acs_biochem_4c00308 crossref_primary_10_1007_s00401_014_1365_0 crossref_primary_10_1016_j_celrep_2020_108538 crossref_primary_10_1007_s00401_019_02070_4 crossref_primary_10_1016_j_neurobiolaging_2020_08_018 crossref_primary_10_1007_s00401_013_1200_z crossref_primary_10_1007_s12035_013_8528_1 crossref_primary_10_1007_s00401_014_1380_1 crossref_primary_10_1007_s11910_015_0582_9 crossref_primary_10_2298_GENSR2203313M crossref_primary_10_1002_ana_24469 crossref_primary_10_1080_10408363_2022_2150833 crossref_primary_10_1007_s11682_020_00429_w crossref_primary_10_1016_j_neurobiolaging_2012_06_008 crossref_primary_10_1212_WNL_0b013e3182a8250c crossref_primary_10_1007_s00415_014_7456_y crossref_primary_10_1002_acn3_50875 crossref_primary_10_1007_s00401_015_1473_5 crossref_primary_10_1002_humu_22244 crossref_primary_10_1186_alzrt148 crossref_primary_10_1590_1980_57642015DN94000413 crossref_primary_10_1038_nrneurol_2012_58 crossref_primary_10_1186_alzrt149 crossref_primary_10_1007_s11910_015_0567_8 crossref_primary_10_1007_s10048_024_00766_8 crossref_primary_10_1186_s40478_024_01911_y crossref_primary_10_1111_cge_12117 crossref_primary_10_3389_fnins_2019_00486 crossref_primary_10_1186_alzrt141 crossref_primary_10_3233_JAD_170913 crossref_primary_10_1007_s00401_013_1237_z crossref_primary_10_1017_cjn_2023_248 crossref_primary_10_1038_mp_2015_159 crossref_primary_10_1093_brain_awz078 crossref_primary_10_1093_bioinformatics_bts725 crossref_primary_10_1111_nyas_12638 crossref_primary_10_1515_revneuro_2023_0060 crossref_primary_10_1016_j_expneurol_2014_05_020 crossref_primary_10_1016_j_neurobiolaging_2013_11_033 crossref_primary_10_1038_s41419_017_0022_7 crossref_primary_10_3390_cells11132066 crossref_primary_10_1007_s00401_012_1048_7 crossref_primary_10_1016_j_neurobiolaging_2013_09_037 crossref_primary_10_1016_j_yneu_2012_05_040 crossref_primary_10_1212_WNL_0000000000004393 crossref_primary_10_3389_fncel_2017_00126 crossref_primary_10_1007_s00401_013_1232_4 crossref_primary_10_1016_j_jalz_2013_09_013 crossref_primary_10_1073_pnas_1219643110 crossref_primary_10_1371_journal_pone_0208383 crossref_primary_10_1016_j_neurobiolaging_2015_07_004 crossref_primary_10_1097_NEN_0000000000000182 crossref_primary_10_3389_fgene_2022_959258 crossref_primary_10_1016_j_bandl_2013_02_004 crossref_primary_10_1016_j_neuron_2013_07_033 crossref_primary_10_1111_ene_12894 crossref_primary_10_1080_13554794_2012_732090 crossref_primary_10_3109_21678421_2013_838586 crossref_primary_10_1007_s00401_014_1286_y |
Cites_doi | 10.1016/j.jns.2010.07.004 10.1111/j.1440-1789.2010.01171.x 10.1126/science.1166066 10.1212/WNL.59.7.1077 10.1212/WNL.51.6.1546 10.1111/j.1750-3639.2007.00052.x 10.1016/0022-510X(94)90191-0 10.1212/WNL.0b013e3181df0a1b 10.1212/01.wnl.0000200048.53766.b4 10.1093/jnen/63.8.801 10.1038/nature05016 10.1016/j.bbadis.2006.01.004 10.1038/ng.442 10.1212/01.wnl.0000187068.92184.63 10.1016/S1474-4422(10)70184-8 10.1136/jnnp.2010.212225 10.1007/s00415-010-5815-x 10.2353/ajpath.2007.070182 10.1007/s00401-011-0845-8 10.1038/ng.536 10.1126/science.1165942 10.1016/j.neuron.2011.09.011 10.1016/j.jocn.2009.05.005 10.1126/science.1154584 10.1212/WNL.0b013e31821103e6 10.1001/archneurol.2010.146 10.1126/science.1134108 10.1007/s00401-008-0402-2 10.1002/ana.21948 10.1212/WNL.0b013e3181a55f1c 10.1212/WNL.58.12.1791 10.1016/j.ajhg.2011.05.015 10.1212/WNL.0b013e31821d767b 10.1212/WNL.44.10.1872 10.1212/WNL.0b013e318202038c 10.1038/31508 10.1136/jnnp.74.11.1516 10.1016/j.neuron.2011.09.010 10.1093/brain/awl030 10.1038/nature08971 10.1038/nature05017 10.1016/j.neuron.2010.11.036 10.1056/NEJM200105313442207 10.1136/jmg.33.12.1022 10.1212/WNL.58.11.1615 10.1093/brain/awm024 10.1007/s00401-007-0285-7 10.1038/364362c0 10.1093/brain/awp248 10.1212/01.wnl.0000319702.37497.72 10.1093/hmg/ddr299 10.1001/archneur.64.2.240 10.1136/jnnp.2009.204081 |
ContentType | Journal Article |
Copyright | 2015 INIST-CNRS |
Copyright_xml | – notice: 2015 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7TK 7X8 |
DOI | 10.1093/brain/awr353 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | Neurosciences Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1460-2156 |
EndPage | 735 |
ExternalDocumentID | 22300876 25589896 10_1093_brain_awr353 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -E4 -~X .2P .55 .GJ .I3 .XZ .ZR 0R~ 1CY 1TH 23N 2WC 354 3O- 4.4 41~ 482 48X 53G 5GY 5RE 5VS 5WA 5WD 6PF 70D AABZA AACZT AAGKA AAIMJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAVLN AAWDT AAWTL AAYJJ AAYXX ABDFA ABDPE ABEJV ABEUO ABGNP ABIME ABIVO ABIXL ABJNI ABKDP ABLJU ABMNT ABNGD ABNHQ ABNKS ABPIB ABPQP ABPTD ABQLI ABQNK ABSMQ ABVGC ABWST ABXVV ABXZS ABZBJ ABZEO ACBNA ACFRR ACGFS ACIWK ACPQN ACPRK ACUFI ACUKT ACUTJ ACUTO ACVCV ACYHN ACZBC ADBBV ADEYI ADEZT ADGKP ADGZP ADHKW ADHZD ADIPN ADMTO ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZXQ AEGPL AEHUL AEJOX AEKPW AEKSI AELWJ AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFQV AFFZL AFGWE AFIYH AFOFC AFSHK AFXAL AFYAG AGINJ AGKEF AGKRT AGMDO AGORE AGQPQ AGQXC AGSYK AGUTN AHGBF AHMBA AHMMS AHXPO AI. AIJHB AJBYB AJDVS AJEEA AJNCP AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX ANFBD APIBT APJGH APWMN AQDSO AQKUS ARIXL ASAOO ASPBG ATDFG ATGXG ATTQO AVNTJ AVWKF AXUDD AYOIW AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BQDIO BR6 BSWAC BTRTY BVRKM BZKNY C1A C45 CAG CDBKE CITATION COF CS3 CXTWN CZ4 DAKXR DFGAJ DIK DILTD DU5 D~K E3Z EBS EE~ EIHJH EJD ELUNK EMOBN ENERS F5P F9B FECEO FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IOX J21 J5H JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z MBLQV MBTAY MHKGH ML0 MVM N4W N9A NGC NLBLG NOMLY NOYVH NTWIH NU- NVLIB O0~ O9- OAUYM OAWHX OBFPC OBOKY OCZFY ODMLO OHH OHT OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RIG RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO TCN TCURE TEORI TJX TLC TMA TR2 VH1 VVN W8F WH7 WOQ X7H X7M XJT XOL YAYTL YKOAZ YQJ YSK YXANX ZCG ZGI ZKB ZKX ZXP ~91 IQODW CGR CUY CVF ECM EIF NPM 7TK 7X8 |
ID | FETCH-LOGICAL-c457t-26e12c5f4e1e824616ea448f2cede9000fa1a2a26040bf329ef8db835a748a1e3 |
ISSN | 0006-8950 1460-2156 |
IngestDate | Thu Jul 10 22:44:51 EDT 2025 Thu Jul 10 18:18:40 EDT 2025 Mon Jul 21 05:58:38 EDT 2025 Mon Jul 21 09:17:56 EDT 2025 Tue Jul 01 00:46:04 EDT 2025 Thu Apr 24 23:08:56 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Nervous system diseases Phenotype Central nervous system disease Amyotrophic lateral sclerosis Degenerative disease Degeneration Frontotemporal dementia Spinal cord disease C9orf72 repeat expansion frontotemporal lobar degeneration Cerebral disorder |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c457t-26e12c5f4e1e824616ea448f2cede9000fa1a2a26040bf329ef8db835a748a1e3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | https://academic.oup.com/brain/article-pdf/135/3/723/17347039/awr353.pdf |
PMID | 22300876 |
PQID | 1434023814 |
PQPubID | 23462 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_923958532 proquest_miscellaneous_1434023814 pubmed_primary_22300876 pascalfrancis_primary_25589896 crossref_citationtrail_10_1093_brain_awr353 crossref_primary_10_1093_brain_awr353 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-03-01 |
PublicationDateYYYYMMDD | 2012-03-01 |
PublicationDate_xml | – month: 03 year: 2012 text: 2012-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Oxford |
PublicationPlace_xml | – name: Oxford – name: England |
PublicationTitle | Brain (London, England : 1878) |
PublicationTitleAlternate | Brain |
PublicationYear | 2012 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Johnson ( key 20170522091325_awr353-B16) 2010; 68 Seelaar ( key 20170522091325_awr353-B42) 2007; 130 Dejesus-Hernandez ( key 20170522091325_awr353-B8) 2011; 72 Thal ( key 20170522091325_awr353-B44) 2002; 58 Maruyama ( key 20170522091325_awr353-B28) 2010; 465 Baker ( key 20170522091325_awr353-B1) 2006; 442 Warner ( key 20170522091325_awr353-B52) 1996; 33 Lillo ( key 20170522091325_awr353-B24) 2010; 67 Rowland ( key 20170522091325_awr353-B39) 2001; 344 Sreedharan ( key 20170522091325_awr353-B43) 2008; 319 van Swieten ( key 20170522091325_awr353-B49) 2007; 17 Renton ( key 20170522091325_awr353-B36) 2011 Hiji ( key 20170522091325_awr353-B13) 2008; 116 Majoor-Krakauer ( key 20170522091325_awr353-B27) 1994; 44 Kim ( key 20170522091325_awr353-B17) 2009; 16 Vance ( key 20170522091325_awr353-B51) 2009; 323 Coon ( key 20170522091325_awr353-B6) 2011; 76 Gorno-Tempini ( key 20170522091325_awr353-B11) 2011; 76 Brooks ( key 20170522091325_awr353-B4) 1994; 124 Goldman ( key 20170522091325_awr353-B10) 2005; 65 Vance ( key 20170522091325_awr353-B50) 2006; 129 Gros-Louis ( key 20170522091325_awr353-B12) 2006; 1762 Polvikoski ( key 20170522091325_awr353-B34) 2003; 74 Laaksovirta ( key 20170522091325_awr353-B22) 2010; 9 Hodges ( key 20170522091325_awr353-B14) 2010; 133 Hutton ( key 20170522091325_awr353-B15) 1998; 393 Kwiatkowski ( key 20170522091325_awr353-B21) 2009; 323 Morita ( key 20170522091325_awr353-B30) 2006; 66 Pearson ( key 20170522091325_awr353-B33) 2011; 258 Todd ( key 20170522091325_awr353-B45) 2010; 67 Zhang ( key 20170522091325_awr353-B54) 2008; 115 Rosen ( key 20170522091325_awr353-B38) 1993; 364 Le Ber ( key 20170522091325_awr353-B23) 2009; 72 Neumann ( key 20170522091325_awr353-B32) 2006; 314 Neary ( key 20170522091325_awr353-B31) 1998; 51 Cairns ( key 20170522091325_awr353-B5) 2007; 171 Valdmanis ( key 20170522091325_awr353-B46) 2007; 64 Boxer ( key 20170522091325_awr353-B3) 2011; 82 Seelaar ( key 20170522091325_awr353-B41) 2011; 82 Van Deerlin ( key 20170522091325_awr353-B47) 2010; 42 Lomen-Hoerth ( key 20170522091325_awr353-B25) 2002; 59 Mok ( key 20170522091325_awr353-B29) 2011; 33 Cruts ( key 20170522091325_awr353-B7) 2006; 442 Seelaar ( key 20170522091325_awr353-B40) 2008; 71 King ( key 20170522091325_awr353-B18) 2011; 31 Wojciechowska ( key 20170522091325_awr353-B53) 2011; 20 Kobayashi ( key 20170522091325_awr353-B19) 2011; 89 Ratnavalli ( key 20170522091325_awr353-B35) 2002; 58 Rohrer ( key 20170522091325_awr353-B37) 2010; 75 Mackenzie ( key 20170522091325_awr353-B26) 2011; 122 Kuwahara ( key 20170522091325_awr353-B20) 2010; 297 Bigio ( key 20170522091325_awr353-B2) 2004; 63 van Es ( key 20170522091325_awr353-B48) 2009; 41 Gliebus ( key 20170522091325_awr353-B9) 2010; 74 |
References_xml | – volume: 297 start-page: 92 year: 2010 ident: key 20170522091325_awr353-B20 article-title: Frontotemporal lobar degeneration with motor neuron disease showing severe and circumscribed atrophy of anterior temporal lobes publication-title: J Neurol Sci doi: 10.1016/j.jns.2010.07.004 – volume: 31 start-page: 239 year: 2011 ident: key 20170522091325_awr353-B18 article-title: Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43 publication-title: Neuropathology doi: 10.1111/j.1440-1789.2010.01171.x – volume: 323 start-page: 1205 year: 2009 ident: key 20170522091325_awr353-B21 article-title: Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis publication-title: Science doi: 10.1126/science.1166066 – volume: 59 start-page: 1077 year: 2002 ident: key 20170522091325_awr353-B25 article-title: The overlap of amyotrophic lateral sclerosis and frontotemporal dementia publication-title: Neurology doi: 10.1212/WNL.59.7.1077 – volume: 51 start-page: 1546 year: 1998 ident: key 20170522091325_awr353-B31 article-title: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria publication-title: Neurology doi: 10.1212/WNL.51.6.1546 – volume: 17 start-page: 63 year: 2007 ident: key 20170522091325_awr353-B49 article-title: Hereditary frontotemporal dementia caused by Tau gene mutations publication-title: Brain Pathol doi: 10.1111/j.1750-3639.2007.00052.x – volume: 124 start-page: 96 year: 1994 ident: key 20170522091325_awr353-B4 article-title: El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors publication-title: J Neurol Sci doi: 10.1016/0022-510X(94)90191-0 – volume: 74 start-page: 1607 year: 2010 ident: key 20170522091325_awr353-B9 article-title: Asymmetric TDP-43 distribution in primary progressive aphasia with progranulin mutation publication-title: Neurology doi: 10.1212/WNL.0b013e3181df0a1b – volume: 66 start-page: 839 year: 2006 ident: key 20170522091325_awr353-B30 article-title: A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia publication-title: Neurology doi: 10.1212/01.wnl.0000200048.53766.b4 – volume: 63 start-page: 801 year: 2004 ident: key 20170522091325_awr353-B2 article-title: Neuronal ubiquitinated intranuclear inclusions in familial and non-familial frontotemporal dementia of the motor neuron disease type associated with amyotrophic lateral sclerosis publication-title: J Neuropathol Exp Neurol doi: 10.1093/jnen/63.8.801 – volume: 442 start-page: 916 year: 2006 ident: key 20170522091325_awr353-B1 article-title: Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 publication-title: Nature doi: 10.1038/nature05016 – volume: 1762 start-page: 956 year: 2006 ident: key 20170522091325_awr353-B12 article-title: Genetics of familial and sporadic amyotrophic lateral sclerosis publication-title: Biochim Biophys Acta doi: 10.1016/j.bbadis.2006.01.004 – volume: 41 start-page: 1083 year: 2009 ident: key 20170522091325_awr353-B48 article-title: Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis publication-title: Nat Genet doi: 10.1038/ng.442 – volume: 65 start-page: 1817 year: 2005 ident: key 20170522091325_awr353-B10 article-title: Comparison of family histories in FTLD subtypes and related tauopathies publication-title: Neurology doi: 10.1212/01.wnl.0000187068.92184.63 – volume: 9 start-page: 978 year: 2010 ident: key 20170522091325_awr353-B22 article-title: Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study publication-title: Lancet Neurol doi: 10.1016/S1474-4422(10)70184-8 – volume: 82 start-page: 476 year: 2011 ident: key 20170522091325_awr353-B41 article-title: Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.2010.212225 – volume: 258 start-page: 647 year: 2011 ident: key 20170522091325_awr353-B33 article-title: Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p publication-title: J Neurol doi: 10.1007/s00415-010-5815-x – volume: 171 start-page: 227 year: 2007 ident: key 20170522091325_awr353-B5 article-title: TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions publication-title: Am J Pathol doi: 10.2353/ajpath.2007.070182 – volume: 122 start-page: 111 year: 2011 ident: key 20170522091325_awr353-B26 article-title: A harmonized classification system for FTLD-TDP pathology publication-title: Acta Neuropathol doi: 10.1007/s00401-011-0845-8 – volume: 42 start-page: 234 year: 2010 ident: key 20170522091325_awr353-B47 article-title: Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions publication-title: Nat Genet doi: 10.1038/ng.536 – volume: 323 start-page: 1208 year: 2009 ident: key 20170522091325_awr353-B51 article-title: Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6 publication-title: Science doi: 10.1126/science.1165942 – volume: 72 start-page: 245 year: 2011 ident: key 20170522091325_awr353-B8 article-title: Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS publication-title: Neuron doi: 10.1016/j.neuron.2011.09.011 – volume: 16 start-page: 1683 year: 2009 ident: key 20170522091325_awr353-B17 article-title: Semantic dementia combined with motor neuron disease publication-title: J Clin Neurosci doi: 10.1016/j.jocn.2009.05.005 – volume: 319 start-page: 1668 year: 2008 ident: key 20170522091325_awr353-B43 article-title: TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis publication-title: Science doi: 10.1126/science.1154584 – volume: 76 start-page: 1006 year: 2011 ident: key 20170522091325_awr353-B11 article-title: Classification of primary progressive aphasia and its variants publication-title: Neurology doi: 10.1212/WNL.0b013e31821103e6 – volume: 67 start-page: 826 year: 2010 ident: key 20170522091325_awr353-B24 article-title: Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis publication-title: Arch Neurol doi: 10.1001/archneurol.2010.146 – volume: 314 start-page: 130 year: 2006 ident: key 20170522091325_awr353-B32 article-title: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis publication-title: Science doi: 10.1126/science.1134108 – volume: 116 start-page: 183 year: 2008 ident: key 20170522091325_awr353-B13 article-title: White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin publication-title: Acta Neuropathol doi: 10.1007/s00401-008-0402-2 – volume: 67 start-page: 291 year: 2010 ident: key 20170522091325_awr353-B45 article-title: RNA-mediated neurodegeneration in repeat expansion disorders publication-title: Ann Neurol doi: 10.1002/ana.21948 – volume: 72 start-page: 1669 year: 2009 ident: key 20170522091325_awr353-B23 article-title: Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease publication-title: Neurology doi: 10.1212/WNL.0b013e3181a55f1c – volume: 58 start-page: 1791 year: 2002 ident: key 20170522091325_awr353-B44 article-title: Phases of A beta-deposition in the human brain and its relevance for the development of AD publication-title: Neurology doi: 10.1212/WNL.58.12.1791 – volume: 89 start-page: 121 year: 2011 ident: key 20170522091325_awr353-B19 article-title: Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2011.05.015 – volume: 76 start-page: 1886 year: 2011 ident: key 20170522091325_awr353-B6 article-title: Predicting survival in frontotemporal dementia with motor neuron disease publication-title: Neurology doi: 10.1212/WNL.0b013e31821d767b – volume: 44 start-page: 1872 year: 1994 ident: key 20170522091325_awr353-B27 article-title: Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility publication-title: Neurology doi: 10.1212/WNL.44.10.1872 – volume: 75 start-page: 2204 year: 2010 ident: key 20170522091325_awr353-B37 article-title: TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia publication-title: Neurology doi: 10.1212/WNL.0b013e318202038c – volume: 393 start-page: 702 year: 1998 ident: key 20170522091325_awr353-B15 article-title: Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 publication-title: Nature doi: 10.1038/31508 – volume: 33 start-page: 209 year: 2011 ident: key 20170522091325_awr353-B29 article-title: The chromosome 9 ALS and FTD locus is probably derived from a single founder publication-title: Neurobiol Aging – volume: 74 start-page: 1516 year: 2003 ident: key 20170522091325_awr353-B34 article-title: Familial motor neurone disease with dementia: phenotypic variation and cerebellar pathology publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.74.11.1516 – year: 2011 ident: key 20170522091325_awr353-B36 article-title: A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD publication-title: Neuron doi: 10.1016/j.neuron.2011.09.010 – volume: 129 start-page: 868 year: 2006 ident: key 20170522091325_awr353-B50 article-title: Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3 publication-title: Brain doi: 10.1093/brain/awl030 – volume: 465 start-page: 223 year: 2010 ident: key 20170522091325_awr353-B28 article-title: Mutations of optineurin in amyotrophic lateral sclerosis publication-title: Nature doi: 10.1038/nature08971 – volume: 442 start-page: 920 year: 2006 ident: key 20170522091325_awr353-B7 article-title: Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 publication-title: Nature doi: 10.1038/nature05017 – volume: 68 start-page: 857 year: 2010 ident: key 20170522091325_awr353-B16 article-title: Exome sequencing reveals VCP mutations as a cause of familial ALS publication-title: Neuron doi: 10.1016/j.neuron.2010.11.036 – volume: 344 start-page: 1688 year: 2001 ident: key 20170522091325_awr353-B39 article-title: Amyotrophic lateral sclerosis publication-title: N Engl J Med doi: 10.1056/NEJM200105313442207 – volume: 33 start-page: 1022 year: 1996 ident: key 20170522091325_awr353-B52 article-title: A general method for the detection of large CAG repeat expansions by fluorescent PCR publication-title: J Med Genet doi: 10.1136/jmg.33.12.1022 – volume: 58 start-page: 1615 year: 2002 ident: key 20170522091325_awr353-B35 article-title: The prevalence of frontotemporal dementia publication-title: Neurology doi: 10.1212/WNL.58.11.1615 – volume: 130 start-page: 1375 year: 2007 ident: key 20170522091325_awr353-B42 article-title: TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without progranulin mutations publication-title: Brain doi: 10.1093/brain/awm024 – volume: 115 start-page: 115 year: 2008 ident: key 20170522091325_awr353-B54 article-title: TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia publication-title: Acta Neuropathol doi: 10.1007/s00401-007-0285-7 – volume: 364 start-page: 362 year: 1993 ident: key 20170522091325_awr353-B38 article-title: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis publication-title: Nature doi: 10.1038/364362c0 – volume: 133 start-page: 300 year: 2010 ident: key 20170522091325_awr353-B14 article-title: Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases publication-title: Brain doi: 10.1093/brain/awp248 – volume: 71 start-page: 1220 year: 2008 ident: key 20170522091325_awr353-B40 article-title: Distinct genetic forms of frontotemporal dementia publication-title: Neurology doi: 10.1212/01.wnl.0000319702.37497.72 – volume: 20 start-page: 3811 year: 2011 ident: key 20170522091325_awr353-B53 article-title: Cellular toxicity of expanded RNA repeats: focus on RNA foci publication-title: Hum Mol Genet doi: 10.1093/hmg/ddr299 – volume: 64 start-page: 240 year: 2007 ident: key 20170522091325_awr353-B46 article-title: Three families with amyotrophic lateral sclerosis and frontotemporal dementia with evidence of linkage to chromosome 9p publication-title: Arch Neurol doi: 10.1001/archneur.64.2.240 – volume: 82 start-page: 196 year: 2011 ident: key 20170522091325_awr353-B3 article-title: Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.2009.204081 |
SSID | ssj0014326 |
Score | 2.5121245 |
Snippet | There is increasing evidence that frontotemporal dementia and amyotrophic lateral sclerosis are part of a disease continuum. Recently, a hexanucleotide repeat... |
SourceID | proquest pubmed pascalfrancis crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 723 |
SubjectTerms | Adult Age of Onset Aged Aged, 80 and over Amyotrophic Lateral Sclerosis - genetics Amyotrophic Lateral Sclerosis - pathology Amyotrophic Lateral Sclerosis - psychology Autopsy Biological and medical sciences C9orf72 Protein Cohort Studies Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases DNA Repeat Expansion DNA-Binding Proteins - genetics Female Frontotemporal Dementia - genetics Frontotemporal Dementia - pathology Frontotemporal Dementia - psychology Genotype Humans Immunohistochemistry In Situ Hybridization Intercellular Signaling Peptides and Proteins - genetics Male Medical sciences Middle Aged Netherlands Neurology Neurons - pathology Neuropsychological Tests Pedigree Polymerase Chain Reaction Proteins - genetics tau Proteins - genetics Tissue Banks |
Title | The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22300876 https://www.proquest.com/docview/1434023814 https://www.proquest.com/docview/923958532 |
Volume | 135 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9NAEF_qCSKI-G39OFbQp5K7yybdJI8qliKcir2DvpXNZoLlrkloUzzu3f_bmd1N0uAV1JdQkm0XZn6d_GZ2Phh7G0tNBR_SQy6uvXAMsRdLJT0fEoKXr7SgeufTL3J6Hn6ej-eDwa-drKVtnR7p6xvrSv5Hq3gP9UpVsv-g2fZH8QZ-Rv3iFTWM17_WcVvaaCr-Vd1ZM8reKk2IlVIukq_fJ5FAYnilCuphXNbLjEamVBQigCs0Cps2dNc2PFLL4saZHzaQEEfxTiBhtlzRqfuHoPBm5vjdLxAQ1zYVl96-LWcuq8pV2VwuqfP1aGfq8Y_Cm5YXNmOIpn2prlRiur2AleO6BVJkF6F1IQvK_Whyto7AmtlQnnhINmTPDtu-JQ5w3-pRsGNYI1uV_IfBt82w0rUJo0zUz3Uw7i1EcVQro37kQab_Xvfia9MRm0e32G0RIQWjmvF5mymEjFJIVzOB2x2bzY7tVtRL2n25R2zuVWqDms7tcJT93othMWcP2H3nfvD3FksP2QCKR-zOqUuweMxmCCneQIqjpvkupHgLKV7m3EGK9yHFLaR4B6kn7Hzy6ezj1HNzNzwdjqPaExJ8ocd5CD7E1G9QgkIvPhcaMqAhs7nylVDoCYcnaR6IBPI4S5HKqyiMlQ_BU3ZQlAU8Z9wHyIM0y7IAIBRRlMQqyn0tdaLjTEg9ZKNGaAvtmtLTbJTLhU2OCBZG2gsr7SF7166ubDOWPesOe_JvF6P_TONS5ZC9aRSyQHNKZ2SqgHK7QU84CA2NDYeM71mDPlGCXnYghuyZVWa3gQPDi71PXrK73V_iFTuo11t4jby2Tg8N6n4DGl-iBw |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+clinical+and+pathological+phenotype+of+C9ORF72+hexanucleotide+repeat+expansions&rft.jtitle=Brain+%28London%2C+England+%3A+1878%29&rft.au=Sim%C3%B3n-S%C3%A1nchez%2C+Javier&rft.au=Dopper%2C+Elise+G+P&rft.au=Cohn-Hokke%2C+Petra+E&rft.au=Hukema%2C+Renate+K&rft.date=2012-03-01&rft.eissn=1460-2156&rft.volume=135&rft.issue=Pt+3&rft.spage=723&rft_id=info:doi/10.1093%2Fbrain%2Fawr353&rft_id=info%3Apmid%2F22300876&rft.externalDocID=22300876 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-8950&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-8950&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-8950&client=summon |